Healthcare stocks often lag in dividend yields compared to other sectors. However, AbbVie and Medtronic stand out as strong dividend payers. These companies, with their size and diversification, are capable of generating consistent revenue growth. Their focus on research and development allows for continued innovation and sustained shareholder returns, making them attractive options for income-focused investors.

AbbVie, a Dividend King, boasts a 2.98% dividend yield, consistently increasing its payouts for over five decades. While its EPS dipped, the company is successfully transitioning its portfolio beyond Humira. Medtronic, the medical device giant, offers a 2.75% yield, supported by steady revenue gains and strategic expansions into smart devices, promising further growth.

Both companies' robust cash flow supports their dividend strategies. AbbVie's oncology portfolio and Medtronic's diverse medical equipment offerings contribute to their financial health. While Medtronic plans to spin off its diabetes business, the move is not expected to affect its dividend. For those seeking reliable income, these healthcare stocks provide a compelling blend of growth and yield.

Investors considering these options should weigh the payout ratios and growth prospects. AbbVie’s dividend payout ratio is slightly high, but cash flow is strong. Medtronic's revenue and earnings are growing, and the separation of their diabetes business should improve the bottom line. Healthcare stocks can be a safe haven for investors seeking consistent income.